Reports Q2 revenue $176.4M, consensus $176.95M. “The team produced solid financial and operational results this quarter as we look forward to the next chapter in the company’s history,” said David Sides, president and chief executive officer of NextGen Healthcare. “I would like to thank our shareholders for their support over the past 40 years as a public company.”
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on NXGN:
- NXGN Upcoming Earnings Report: What to Expect?
- NextGen Healthcare price target raised to $23.95 from $18 at Truist
- NextGen Healthcare downgraded to Neutral from Overweight at Cantor Fitzgerald
- NextGen Healthcare downgraded to Neutral from Buy at Guggenheim
- NextGen Healthcare downgraded to Equal Weight from Overweight at Stephens
